Background: T cells expressing chimeric antigen receptors (CARs) have shown exciting promise in cancer therapy, particularly in the treatment of B-cell malignancies. However, optimization of CAR-T cell production remains a trial-and-error exercise due to a lack of phenotypic benchmarks that are clearly predictive of anti-tumor functionality. A close examination of the dynamic changes experienced by CAR-T cells upon stimulation can improve understanding of CAR-T-cell biology and identify potential points for optimization in the production of highly functional T cells. Methods: Primary human T cells expressing a second-generation, anti-CD19 CAR were systematically examined for changes in phenotypic and functional responses to antigen exposure...
Adoptive T-cell therapy has emerged as one of the most promising treatment modalities for cancer. CD...
Abstract Background Chimeric antigen receptor (CAR) T-cells have revolutionized the treatment of CD1...
T cell engineering strategies have emerged as successful immunotherapeutic approaches for the treatm...
Background: T cells expressing chimeric antigen receptors (CARs) have shown exciting promise in canc...
BackgroundT cells expressing chimeric antigen receptors (CARs) have shown exciting promise in cancer...
BackgroundT cells expressing chimeric antigen receptors (CARs) have shown exciting promise in cancer...
Background aims: Chimeric antigen receptor (CAR) T cells are a novel immunotherapy for cancer. To ac...
Background: Current advancements in the field of chimeric antigen receptor (CAR) therapy, particular...
This study compared second-generation chimeric antigen receptors (CAR) encoding signaling domains co...
In the past decade, chimeric antigen receptor (CAR) T cell technology has revolutionized cancer immu...
With breakthroughs in synthetic biology, improved cell culture techniques and advanced genetic engin...
With breakthroughs in synthetic biology, improved cell culture techniques and advanced genetic engin...
© 2014 Dr. Connie DuongAdoptive immunotherapy is a promising treatment for cancer, with response rat...
Background: The CD19 chimeric antigen receptor (CAR) adoptive T-cell therapy for B-cell leukemia is ...
Rapid advances in immunotherapy have identified adoptive cell transfer as one of the most promising ...
Adoptive T-cell therapy has emerged as one of the most promising treatment modalities for cancer. CD...
Abstract Background Chimeric antigen receptor (CAR) T-cells have revolutionized the treatment of CD1...
T cell engineering strategies have emerged as successful immunotherapeutic approaches for the treatm...
Background: T cells expressing chimeric antigen receptors (CARs) have shown exciting promise in canc...
BackgroundT cells expressing chimeric antigen receptors (CARs) have shown exciting promise in cancer...
BackgroundT cells expressing chimeric antigen receptors (CARs) have shown exciting promise in cancer...
Background aims: Chimeric antigen receptor (CAR) T cells are a novel immunotherapy for cancer. To ac...
Background: Current advancements in the field of chimeric antigen receptor (CAR) therapy, particular...
This study compared second-generation chimeric antigen receptors (CAR) encoding signaling domains co...
In the past decade, chimeric antigen receptor (CAR) T cell technology has revolutionized cancer immu...
With breakthroughs in synthetic biology, improved cell culture techniques and advanced genetic engin...
With breakthroughs in synthetic biology, improved cell culture techniques and advanced genetic engin...
© 2014 Dr. Connie DuongAdoptive immunotherapy is a promising treatment for cancer, with response rat...
Background: The CD19 chimeric antigen receptor (CAR) adoptive T-cell therapy for B-cell leukemia is ...
Rapid advances in immunotherapy have identified adoptive cell transfer as one of the most promising ...
Adoptive T-cell therapy has emerged as one of the most promising treatment modalities for cancer. CD...
Abstract Background Chimeric antigen receptor (CAR) T-cells have revolutionized the treatment of CD1...
T cell engineering strategies have emerged as successful immunotherapeutic approaches for the treatm...